RxDoctor Payments Data

William Lin, MD

Dermatology · Boston, MANPI 1619255502

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 10th percentile of 552 dermatology providers in Massachusetts.

See all dermatology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$493,664
Medicare patients
2,426
Services billed
5,687

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab22$79,774
Fluorouracil75$4,134
Betamethasone Dipropionate40$2,896
Clobetasol Propionate23$2,717
Ketoconazole41$536
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc14$524
Tretinoin11$479
Imiquimod11$477
Triamcinolone Acetonide19$276

Paid to pharmacies, not to this prescriber.

Other dermatology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →